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Abstract: Fishery wastes are one of natural resources to extract bioactive substances such as 
collagen and glycosaminoglycan (GAG). The anticoagulant activity of glycosaminoglycans extracted 
from Binni fish, Mesopotamichthys sharpeyi scales was the aim of this study. The cationic salt of 
cetyl pyridinium chloride was used to extract the glycosaminoglycan. The structure of the isolated 
glycosaminoglycan was identified by ELISE glycosaminoglycan kit and compared to that of heparin. 
Prothrombin time (PT), and thrombin time (TT) on plasma of male mice at three concentrations of 
20, 40, and 100 g/ml were used to determine the coagulant property of the extracted substance. The 
extracted glycosaminoglycan was calculated to be around 27.7 mg/g of dry tissue. The presence of 
heparin-like molecules in the glycosaminoglycan isolated from fish scales was confirmed by ELISE 
GAG kit. When the concentration of isolated glycosaminoglycan was increased, the time to coagulate 
rose. The PT and TT coagulation times were 4:1 and 2:1. Times faster than the control at 100 g/ml. 
When compared to synthetic anticoagulant substances like heparin, the glycosaminoglycan isolated 
from fish scales displayed good anticoagulation qualities. 
  
Introduction 
Glycosaminoglycans are polysaccharides with a 
negative charge (Capila and Linhardt, 2002), 
involving in variety of biological functions, including 
angiogenesis, host defense against viral infection, and 
blood coagulation (Zhao et al., 2013). They are 
divided into four families based on their disaccharide 
composition viz. chondroitin sulfate CS, keratan 
sulfate KS, hyaluronic acid HA, and heparin sulfate 
HS (Yamada and Sugahara, 2008). Heparin is a 
sulphated GAGs with anticoagulant properties 
utilizing in the treatment of viral infections, 
inflammation, and cellular proliferation in wounds 
and cancer, as well as in the acute coronary syndrome, 
lung embolism, vascular fibrillation, and deep 
pulmonary thumbs (Linhardt, 2003).  
Glycosaminoglycans are special type of 
glycoprotein (Neil et al., 2005) that are prevalent in 
cartilages, vasculature, cell surfaces, intracellular 
granules, and plasma and other vertebrate’s organs 
(Clarke, 2004; Im et al., 2013). All of these are by-
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products of the meat and animal industries (Volpi and 
Maccari, 2002) from guts and lung of cows and pigs 
(Linhardt and Claude, 2003). As the demand for 
glycosaminoglycan’s rises, alternative marine 
resources are being used more frequently as a result, 
aquatic vertebrates and invertebrates have recently 
become increasingly important suppliers of 
glycosaminoglycan’s (Rajapakse et al., 2005). Several 
researches are concentrating on the extraction of 
glycosaminoglycans using marine sources (Goldberg 
and Buckwalter, 2005). Bluefin tuna bone, jellyfish 
cartilaginous, and fishery wastes as potential 
Glycosaminoglycan’s sources (Maccari et al., 2015).  
Reason of mortality in the poor countries, are 
disorders resulting from defective clotting in the 
circulatory system (Zhang et al., 2014). To inhibit 
platelet aggregation and restore blood circulation via 
capillaries, medicines having anti-thrombotic, 
anticoagulant, and antiplatelet characteristics are 
utilized (Vazquez et al., 2013). The existence of 
heparin and heparin derivatives in marine creatures, 
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 particularly squids, has been discovered (Akbulut and 
Akgul, 2014; Pan et al., 2017). One of significant 
economic fish in Iraq is the binni, Mesopotamichthys 
sharpeyi that has substantial wastes during its process 
especially scales, and the scales might be a promising 
bioactive substances resource (Tingbø et al., 2005). 
Therefore, in this study scales were used to extract 
glycol-saminoglycan (GAG) and assess their 
anticoagulant effectiveness in vitro utilizing 
traditional coagulation assays (World Health 
Organization 2008). 
 
Materials and Methods 
Sampling and preparation: Scales of the binni were 
obtained from a fish market in Al-Diwaniyah, Iraq. To 
produce the dry powder, the fish scales were cleaned 
thoroughly with tap water, freeze-dried, then ground 
in a mixer. A total of 5 g scale powder was incubated 
for 1 hr at 80°C in 100 ml of MgSO4 8.0 mM, then 
NaCl was used to raise the pH of the solution to 10. 
The pH was then reduced to 7 using ammonium 
sulfate (2S04NH4) and heated at 50°C for 120 minutes. 
After filtering, the solution has been subjected to 
CINH 38 C21 / benzydamin (CPC). The filtrate was 
then treated with 20 ml of CPC (3: 0.8 M Nacl). The 
solution was kept at 37°C for 1 day, resulting in a 
white color precipitate. 5 ml NaCl before heated to 
50°C was applied to extract N5H5C salt from of the 
precipitation. The sulfonated polysaccharide was 
precipitated with 75% ethanol and afterward the 
methanol was used to wash the precipitate multiple 
times before freeze-drying for an hour (Najjam et al., 
1997; Tomatsu et al., 2005; Gui et al., 2015) (Fig. 1). 
Glycolsaminoglycans (GAGs) detection: GAGs are 
extensively dispersed and, based on the particular 
GAG, are linked to physiological and pathological 
functions. As a result, the development of precise, 
quick, sensitive, and specific assays of certain GAGs 
is critical. GAGs are used not only for diagnosis and 
therapeutic efficiency, but for many other 
abnormalities in which are down or up regulated, such 
as mucolipidoses (Tomatsu et al., 2005), cancer (Yip 
et al., 2006), osteoarthritis (Plaas et al., 1998), 
rheumatoid arthritis (Wang and Roehrl, 2002), 
diabetes (Olczyk et al., 1997), infectious diseases (Iaci 
et al., 2007), and spinal cord damage (Aydin, 2015; 
Engvall, 2010).  
In this study, glycolsaminoglycans assay kit 
(Colorimetric method) we used and for this purpose 
enzyme-linked immunosorbent assay (480 nm) 
bought from Chondrex Company (Woodinville, WA 
98072, USA) and using the company protocol, the 
antigen is bound to an antibody that is coupled to an 
enzyme, and antigen is detected by hydrolysis of a 
substrate by the linked enzymes (Mucci et al., 2000; 
Shute, 2012). 
Coagulant test: The anticoagulation test was 
performed using citrated ICR mice platelet deficient 
plasma. The plasma was taken from 36 male mice 
(with 20±2 g weight) after dividing into 3 groups as 
control, glycolsaminoglycans and Heparin treatments 
each containing 12 mice. The plasma was mixed with 
0.5% Na3C6H5O7 solution as 99:1 blood to sodium 
citrate. The plasma was prepared by centrifuging at 
5400 g for 25 min and then filtered and kept at -50°C 
until to use (Krylov et al., 2011). Standard clotting 
assays were used to determine the anticoagulant action 
of the isolated prothrombin time (PT), and thrombin 
time (TT). Sodium hydroxide was used to dissolve the 
sample glycolsaminoglycans. All of the procedures 
had been done three times (Majdoub et al., 2009). 
Evaluating prothrombin time (PT): 70 pl of mice 
plasma was mixed with 30 pl heparin, 30 g/mL NaCl, 
and different concentrations of isolated GAGs (20, 50, 
Figure 1. Mesopotamichthys sharpeyi (1), Fish scales (2) 
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and 100 pg/l) to measure the PT. For 15 minutes, the 
mixes were incubated at 50°C (Chondrex, USA). Then 
100 pl of thromboplastin reagent before incubating at 
50°C PT was added, and the clotting time was 
measured using a coagulometer (Garnjanagoonchorn 
et al., 2007). 
Evaluating thrombin time (TT): 70 pl of mice 
plasma were mixed 10 s of various GAG levels (20, 
40, and 100 pg/mL) and incubated at 50°C for 5 
minutes. The TT was then recorded when 100 pl of 
thrombin was added. Heparin and NaCl were used as 
control sample, consequently, in place of the 10 pl of 
glycolsaminoglycans (Pomin and Mulloy, 2015). 
Data analysis: Due to the normal distribution, two-
way analysis of variance ANOVA was employed to 
compare the groups. In addition, as a post hoc test, the 
Duncan multiple-range test was used. The mean and 
standard deviation were used to express all of the data 
(SE). P<0.05 was used to determine the significance 
of the difference. SPSS software version 20.0 was 
used for data analysis. 
 
Results  
The anticoagulant properties of the extracted 
glycolsaminoglycans are shown in Table 1. The mean 
of PT and TT for mice plasmas were 20.4±0.4, 
16.0±0.3 seconds, respectively. There was a 
significant difference in PT and TT between 
concentrations of the extracted glycolsaminoglycans 
(P<0.05). The anticoagulant indices of glycols-
aminoglycans of fish scale increased as the 
concentrations of glycolsaminoglycans elevated. The 
prolonged coagulation times were observed in the 
presence of the extracted glycolsaminoglycans at the 
same concentrations, compared to control. At a 
concentration of 3 100 g/mL, the PT and TT glycols-
aminoglycans of were 20.4±0.4 and 19.4±0.6 seconds, 
respectively which was 4 and 2 times slower than the 
control group. Although, in the PT (P<0.05), there was 
significant variance between glycolsaminoglycans 
and heparin compared with control group. 
 
Discussions 
Anticoagulant properties are found in heparin and 
heparin-like substances such as Glycolsaminoglycans 
and keratan sulphate in marine fishes (Athukorala et 
al., 2006). The quantity of glycolsaminoglycans found 
in fish scale of the binni fish was 27.7mg/g of tissue. 
Salmo salar, Somniosus microcephalus, Galeus 
melastomus, Deania calcea, Amblyraja hyperborea, 
and Acipenser sinensis had 10.31, 13.96, 7.53, 6.66, 
and 15.51g of the sulphated Glycolsaminoglycans 
from their cartilage in pervious researches, 
respectively (Plaas et al., 1998; Tomatsu et al., 2005; 
Maccari et al., 2015). Furthermore, the amount of 
glycolsaminoglycans extracted from 100 g of squid 
shell was estimated to be around 2 g /100 g dry weight 
(Yang et al., 2015). 
Coagulation analyzes of PT, and TT were 
performed in this work to assess anticoagulant 
activity. Intrinsic and extrinsic coagulation cascades 
are assessed using the PT test and the TT test assesses 
the fibrin polymerization process. The findings of the 
Table 1. Relationship between protheombin time (PT) and thrombin (TT) with glycosaminoglycan as PT at various concentrations (/ml). 
       PT 20 40 100 P 
Glycolsaminoglycans   20.4±0.4 <0.05 
Heparin   23.6±0.7 <0.05 
Control 10.2±0.3 10.2±0.3 10.2±0.3  
Control 12.7±0.5 12.7±0.5 12.7±0.5  
Glycolsaminoglycans 20.5±0.4 23.5±1.2 24.7±0.2 <0.05 
    The results were expressed as means ±SE (n = 12/group) 
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 TT showed that scale glycolsaminoglycans can extend 
the coagulation time by 4:1 to 2: 1 times. There were 
significant variations in PT in the influence of 
glycolsaminoglycans. Anticoagulant action of 
chondroitin sulphate isolated from various fish 
species, i.e. shark and sturgeon cartilage, has also been 
observed (Pan et al., 2017). The glycolsaminoglycans 
extracted from sea cucumber produced similar results, 
with longer coagulation times as the content of 
glycolsaminoglycans elevated (Yip et al., 2006). 
As a result, scale glycolsaminoglycans seem to 
have effect on the activity of extrinsic clotting factors. 
The increased TT levels imply that scale 
glycolsaminoglycans can influence the action of 
intrinsic coagulation factors and thrombin (Engvall, 
2010). Heparin, for example, is a similar glycols-
aminoglycans molecule with a wide range of 
biological functions. Several factors, including 
species, structural composition, and sulphating 
patterns of glucose amines, might alter the 
anticoagulation function of glycolsaminoglycans 
substances (Goldberg and Buckwalter, 2005; Tomatsu 
et al., 2005; Maccari et al., 2015). 
The size of the scales’ mono-sulfated 
disaccharides, which are found in 
glycolsaminoglycans, play an important role in 
anticoagulation and anti-thrombin activities. The 
interaction of glycolsaminoglycans with the factors 
involved in the coagulation pathway results in a 
decrease in factor activity and an increase in clotting 
times (Majdoub et al., 2009; Pomin and Mulloy, 
2015). When compared to heparin, glycols-
aminoglycans compounds isolated from fish scales 
demonstrated reduced coagulant activity. It is 
probably the amount of pollutants in the extracted 
glycolsaminoglycans molecules is to blame (Plaas et 
al., 1998; Iaci et al., 2007). The CPC method could 
extract a large amount of glycolsaminoglycans 
compound from fish scales. The coagulation tests PT, 
and TT revealed that the glycolsaminoglycans 
molecules might delay coagulation periods. Finally, 
non-usable scales of fish can be a useful source of 
biological active chemicals (Engvall, 2010; Aydin, 
2015). As conclusion, glycolsaminoglycans from fish 
scales were found to have coagulant properties by 
delayed prothrombin and thrombin times in the 
plasma of male mice and it can be used as a heparin 
alternative, at least in experimental studies.  
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